EPSIX | TRZRX | EPSIX / TRZRX | |
Total Expense Ratio | 1.17 | 0.00 | - |
Annual Report Gross Expense Ratio | 1.18 | 0.65 | 182% |
Fund Existence | 16 years | 5 years | - |
Gain YTD | 9.331 | 10.308 | 91% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 775M | 10.8B | 7% |
Annual Yield % from dividends | 1.97 | 2.40 | 82% |
Returns for 1 year | 7.93 | 10.51 | 75% |
Returns for 3 years | 39.60 | 22.80 | 174% |
Returns for 5 years | 67.31 | 65.01 | 104% |
Returns for 10 years | 41.39 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 65.07 | -0.41 | -0.63% |
Janus Henderson Global Life Sciences A | |||
VIGIX | 215.36 | -2.91 | -1.33% |
Vanguard Growth Index Institutional | |||
FDIGX | 85.04 | -1.18 | -1.37% |
Fidelity Advisor Consumer Staples I | |||
NBMIX | 46.67 | -0.68 | -1.44% |
Neuberger Berman Small Cap Growth Inv | |||
MSAYX | 22.55 | -0.39 | -1.70% |
Morgan Stanley Inst Asia Opp R6 |